Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asad Bashey

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Bone Marrow Transplantation|March 6, 2019
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Transplantation and Cellular Therapy|January 17, 2026
Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trialJoseph Pidala, Brent Logan, Stephanie J Lee, et al.
Transplantation and Cellular Therapy|September 11, 2024
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA AntibodiesPiyanuch Kongtim, Pongthep Vittayawacharin, Jun Zou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic LeukemiaBetty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional TrialJason G Dehn, Brent Logan, Bronwen E Shaw, et al.
Blood Advances|June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment TrialAsad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Transplantation and Cellular Therapy|November 10, 2025
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 TrialJason G Dehn, Brent Logan, Stephanie J Lee, et al.
Blood|July 2, 2015
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemiaStefan O Ciurea, Mei-Jie Zhang, Andrea A Bacigalupo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2009
Race and outcomes of autologous hematopoietic cell transplantation for multiple myelomaParameswaran N Hari, Navneet S Majhail, Mei-Jie Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2010
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR studyDonna E Reece, David H Vesole, Smriti Shrestha, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Bone Marrow Transplantation|March 6, 2019
The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantationStefan O Ciurea, Monzr M Al Malki, Piyanuch Kongtim, et al.
Transplantation and Cellular Therapy|January 17, 2026
Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trialJoseph Pidala, Brent Logan, Stephanie J Lee, et al.
Transplantation and Cellular Therapy|September 11, 2024
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA AntibodiesPiyanuch Kongtim, Pongthep Vittayawacharin, Jun Zou, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 12, 2017
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic LeukemiaBetty Ky Hamilton, Lisa Rybicki, Donna Abounader, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional TrialJason G Dehn, Brent Logan, Bronwen E Shaw, et al.
Blood Advances|June 9, 2026
Donor-Specific Transplant Outcomes from BMTCTN 1702: A Multi-Center Prospective Biological-Assignment TrialAsad Bashey, Brent R Logan, LaQuisa C Hill, et al.
Transplantation and Cellular Therapy|November 10, 2025
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 TrialJason G Dehn, Brent Logan, Stephanie J Lee, et al.
Blood|July 2, 2015
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemiaStefan O Ciurea, Mei-Jie Zhang, Andrea A Bacigalupo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2009
Race and outcomes of autologous hematopoietic cell transplantation for multiple myelomaParameswaran N Hari, Navneet S Majhail, Mei-Jie Zhang, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 16, 2010
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR studyDonna E Reece, David H Vesole, Smriti Shrestha, et al.
Pageof 13